Pulse Biosciences, Inc. (PLSE) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 10, 2026 10:00 AM EDT
Company Participants
Paul LaViolette – President, CEO & Co-Chairman of the Board
Presentation
Unknown Analyst
We’ll go ahead and get started with our next presentation. Very pleased to have management team from Pulse Biosciences, Paul LaViolette, President, CEO and Chairman here today to talk about the business. I make this offer in every session. This is interactive. Happy to take questions from people in the audience. If you do have a question, just wave me and we’ll get you a mic. So it’s available to those participating via webcast.
Question-and-Answer Session
Unknown Analyst
Maybe we just kind of start higher level. You’ve been at Pulse maybe 1.5 years or so. And give us a little bit of background, like what attracted you to the role? What did you see in the company? And how does this compare to kind of the bevy of other opportunities that you’ve seen across the?
Paul LaViolette
President, CEO & Co-Chairman of the Board
Yes. Well, thank you, David. It’s great to be here. I think it compares really favorably to use your phrase to the bevy of opportunities. If I think about what attracted me — it’s not surprising, right, with what’s going on in the field of PFA in the last couple of years that PFA by definition, draws interest. But there are a lot of PFA companies. PFA is actually a relatively standard technology today. What drew me to this was the uniqueness of the form of energy, and we can talk about it in more detail, but it is a nanosecond. It’s a highly differentiated form of PFA. PFA has the potential to treat so many maladies because of its unique nonthermal ablation form. And I saw in this company a fantastic team, great backers, tremendous innovation, 250 patents, the potential to own a
You must be logged in to post a comment Login